 |
市場調查報告書
商品編碼
2077584
全球腎上腺素自動注射器市場：按類型、最終用戶、分銷管道和地區分類Global Epinephrine Autoinjector Market, By Type, By End User, By Distribution Channel, By Geography |
||||||
全球腎上腺素自動注射器市場預計在 2026 年達到 29.9 億美元，預計到 2033 年將達到 54.6 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 9.0%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 29.9億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 9.00% | 2033年市場規模預測： | 54.6億美元 |
腎上腺素自動注射器是一種一次性使用的自動注射裝置，用於緊急治療過敏反應，包括過敏性休克。過敏性休克是一種危及生命的疾病，由對某些食物、藥物、昆蟲叮咬或其他過敏原的嚴重過敏反應引起。過敏性休克的症狀包括低血壓、口腔和喉嚨腫脹、皮疹、呼吸困難和休克。如果發生過敏性休克，必須迅速注射腎上腺素以防止症狀惡化。與注射器相比，腎上腺素自動注射器可以更快地自行注射腎上腺素，從而降低死亡風險。
市場動態：
全球腎上腺素自動注射器市場的成長主要受全球過敏性休克發病率上升的驅動。根據美國食品過敏和過敏性休克網路（FAAN）發布的數據顯示，光是在美國，每年就有5萬例過敏性休克病例，其中150至200例死亡。人們對過敏症危及生命的認知不斷提高，以及先進腎上腺素自動注射器的普及，正在推動市場需求的成長。然而，這些設備的成本以及開發中國家對替代療法的偏好限制了市場成長。預計未來幾年，開發出更容易使用、更精準、更適用的創新腎上腺素自動注射器，將為製造商帶來龐大的商機。
腎上腺素自動注射器市場正經歷顯著的發展趨勢，這主要得益於技術進步、人們對過敏反應的認知不斷提高以及對方便用戶使用型設計的日益重視。無針注射替代方案和用於培訓的數位化健康平台正受到越來越多的關注，從而提升了患者的舒適度和使用便利性。此外，市場也積極適應疫情帶來的變化，這要求醫療系統和供應鏈具備更強的韌性。持續的創新、設備改進和策略合作正在進一步塑造腎上腺素自動注射器市場，旨在滿足高風險族群和醫療專業人員在快速變化的醫療環境中的需求。
本研究的主要特點：
- 本報告對全球腎上腺素自動注射器市場進行了詳細分析，提出了 2026 年至 2033 年預測期內的市場規模和複合年成長率 (CAGR%)，其中 2025 年為基準年。
- 此外，它還指出了各個細分市場的潛在商機，並說明了該市場中一個有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本報告根據以下參數介紹了全球腎上腺素自動注射器市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 全球腎上腺素自動注射器市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用分析全球腎上腺素自動注射器市場中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 過敏反應發生率增加
- 食物過敏盛行率增加
- 影響分析
- 主要亮點
- 監管趨勢
- 服務提供組合
- PEST分析
- 波特的分析
- 併購情景
- 管道分析
第4章 全球腎上腺素自動注射器市場：按類型分類，2021-2033年
- 0.15mg
- 0.3mg
- 0.5mg
第5章 全球腎上腺素自動注射器市場：依最終用戶分類，2021-2033年
- 醫院
- 診所
- 個人客戶
第6章 全球腎上腺素自動注射器市場：依通路分類，2021-2033年
- 零售藥房
- 醫院藥房
- 網路藥房
第7章 全球腎上腺素自動注射器市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第8章 競爭情勢
- Mylan
- Teva Pharmaceutical
- Impax Laboratories
- Adamis Pharmaceuticals Corporation
- Pfizer
- ALK Abello
- Lincoln Medical
- Hospira
- Sanofi
- Kaleo
第9章
- 調查方法
- 關於本公司
Global Epinephrine Autoinjector Market is estimated to be valued at USD 2.99 Bn in 2026 and is expected to reach USD 5.46 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.99 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.00% | 2033 Value Projection: | USD 5.46 Bn |
Epinephrine autoinjector is a single-use disposable automatic injection device that is intended for emergency treatment of allergic reactions including anaphylaxis. Anaphylaxis is a life-threatening condition that occur due to an extreme allergic reaction to certain foods, medicines, insects bites and other allergens. The symptoms of anaphylaxis include low blood pressure, swelling of the mouth or throat, rashes, breathing difficulty and shock. In case of anaphylaxis, epinephrine needs to be administered in a timely manner to curb the advancement of symptoms. Epinephrine autoinjectors enable rapid self-administration of epinephrine as compared to syringes, thereby, reducing the risk of casualty.
Market Dynamics:
Global epinephrine autoinjector market growth is driven by rising prevalence of anaphylaxis worldwide. According to the data published by FAAN (The Food Allergy and Anaphylaxis Network), 50,000 cases of anaphylaxis occur annually in the U.S. alone, out of which 150-200 result in death. Increased awareness regarding life-threatening conditions associated with allergies along with availability of advanced epinephrine autoinjector devices are fueling the market demand. However, cost of these devices and preference for alternative treatment options in developing nations limits the market growth. Development of innovative epinephrine autoinjectors with improved usability, accuracy and larger coverage area is expected to present lucrative opportunities for manufacturers in the coming years.
The epinephrine autoinjector market is witnessing notable trends, driven by advancements in technology, increased awareness of anaphylaxis, and a growing emphasis on user-friendly designs. Needle-free alternatives and digital health platforms for training are gaining prominence, enhancing patient comfort and accessibility. The market is also responding to the evolving landscape influenced by the pandemic, necessitating adaptability in healthcare systems and supply chains. Continuous innovation, improved device features, and strategic collaborations are further shaping the dynamics of the epinephrine autoinjector market, aiming to address the needs of at-risk individuals and healthcare providers in a rapidly changing healthcare environment.
Key features of the study:
- This report provides in-depth analysis of the global epinephrine autoinjector market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2026-2033, considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global epinephrine autoinjector market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Mylan, Teva Pharmaceutical, Impax Laboratories, Adamis Pharmaceuticals Corporation, Pfizer, ALK Abello, Lincoln Medical, Hospira, Sanofi, and Kaleo
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global epinephrine autoinjector market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epinephrine autoinjector market
Detailed Segmentation:
- Global Epinephrine Autoinjector Market, By Type (Revenue, USD Bn, 2021 - 2033)
- 15mg
- 3mg
- 5mg
- Global Epinephrine Autoinjector Market, By End-User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Individual Customers
- Global Epinephrine Autoinjector Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global Epinephrine Autoinjector Market, Key Players
- Mylan
- Teva Pharmaceutical
- Impax Laboratories
- Adamis Pharmaceuticals Corporation
- Pfizer
- ALK Abello
- Lincoln Medical
- Hospira
- Sanofi
- kaleo
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Epinephrine Autoinjector Market, By Type
- Global Epinephrine Autoinjector Market, By End User
- Global Epinephrine Autoinjector Market, By Distribution Channel
- Global Epinephrine Autoinjector Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing prevalence of anaphylaxis
- Rising Prevalence of Food Allergies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Pipeline Analysis
4. Global Epinephrine Autoinjector Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 0.15mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- 0.3mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- 0.5mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Epinephrine Autoinjector Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Individual Customers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Epinephrine Autoinjector Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Epinephrine Autoinjector Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Mylan
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Impax Laboratories
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Adamis Pharmaceuticals Corporation
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ALK Abello
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lincoln Medical
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hospira
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kaleo
- Company Highlights
- Type Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
預填充充式腎上腺素自動注射器市場：全球市場預測，2026-2032年
腎上腺素自動注射器市場報告：按劑量、應用、最終用戶和地區分類（2026-2034 年）
2030 年腎上腺素自動注射器市場預測：按產品、劑量、年齡層、品牌、應用、最終用戶和地區進行的全球分析